Visualizing the resolution of innate immune responses during influenza infection

可视化流感感染期间先天免疫反应的解决

基本信息

  • 批准号:
    10084273
  • 负责人:
  • 金额:
    $ 19.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-01-15 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

Evidence from recent major epidemics suggests that both direct viral cytopathicity and inflammation-mediated tissue damage are equally important factors that potentiate the host lethality. Thus, the therapeutic strategy to bridle excessive immune damage has been proposed for severe respiratory infections. While clearance of influenza-infected cells is primarily mediated by cytotoxic CD8+ T cells, the now well-established dependency of anti-viral host responses on both innate and adaptive immune compartments suggests that harnessing the innate immunity might form a basis for the development of effective vaccines and novel therapeutic approaches. Early recruitment of leukocytes from the blood to sites of tissue infection is a hallmark of innate immune responses. However, it is currently not known how apoptotic immune cells are removed within inflamed tissues during the resolution phase – a process fundamental to our understanding and manipulation of inflammatory diseases. Despite recent advances in studies concerning phagocytic removal of apoptotic cells, the visualization of the dynamic cell clearance process in vivo has been extremely challenging. Here we propose to develop a novel intravital multi-photon microscopy (IV-MPM) system to address critical knowledge gaps regarding the function and fate of innate immune cells during the influenza infection, and their roles in anti-viral immune responses. We will (1) develop the IV-MPM system to visualize in situ neutrophil efferocytosis during resolution of influenza infection in the upper (trachea) and lower (lung) airway, and (2) develop a novel tissue-resident phagocyte fate-mapping assay to study the immunological consequence of the neutrophil efferocytosis. With these new approaches in a mouse influenza infection model, we will be able to identify novel interactions between innate and adaptive immune systems during the influenza infection. Given the importance of dynamic immune modulatory properties during viral infections, the development of novel research tools to elucidate the relationship between innate immunity and effector T cell interactions at the site of infection is critical for deciphering the basis of productive and nonproductive adaptive immune responses and for advancing our capacity to develop new universal vaccines that rely on such cell mediated responses.
最近主要流行病的证据表明,病毒的直接细胞致病性和炎症介导的组织损伤都是增强宿主致死性的同等重要的因素。因此,针对严重呼吸道感染提出了遏制过度免疫损伤的治疗策略。虽然流感感染细胞的清除主要是由细胞毒性CD8+T细胞介导的,但现在公认的抗病毒宿主反应对天然免疫和获得性免疫间隔的依赖表明,利用天然免疫可能形成有效疫苗和新治疗方法的开发基础。白细胞从血液中早期募集到组织感染部位是先天免疫反应的一个标志。然而,目前尚不清楚炎性组织中的凋亡免疫细胞是如何在消退阶段被移除的--这一过程对于我们理解和操纵炎症性疾病是至关重要的。尽管最近关于吞噬清除凋亡细胞的研究取得了进展,但体内动态细胞清除过程的可视化一直是极具挑战性的。在这里,我们建议开发一种新的活体多光子显微镜(IV-MPM)系统,以解决关于流感感染期间天然免疫细胞的功能和命运以及它们在抗病毒免疫反应中的作用的关键知识空白。我们将(1)开发IV-MPM系统,以在解决上(气管)和下(肺)呼吸道流感感染期间原位显示中性粒细胞吞噬作用,以及(2)开发一种新的组织驻留吞噬细胞命运图分析,以研究中性粒细胞吞噬作用的免疫学后果。在小鼠流感感染模型中使用这些新方法,我们将能够识别流感感染期间先天免疫系统和获得性免疫系统之间的新交互作用。鉴于病毒感染过程中动态免疫调节特性的重要性,开发新的研究工具来阐明先天免疫和感染部位效应器T细胞相互作用之间的关系,对于破译生产性和非生产性适应性免疫反应的基础,以及提高我们开发依赖于这种细胞介导反应的新的通用疫苗的能力至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Minsoo Kim其他文献

Minsoo Kim的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Minsoo Kim', 18)}}的其他基金

Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
  • 批准号:
    10515703
  • 财政年份:
    2022
  • 资助金额:
    $ 19.25万
  • 项目类别:
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
  • 批准号:
    10643889
  • 财政年份:
    2022
  • 资助金额:
    $ 19.25万
  • 项目类别:
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
  • 批准号:
    10832821
  • 财政年份:
    2022
  • 资助金额:
    $ 19.25万
  • 项目类别:
Functional genomic investigation of complement signaling in the human brain
人脑补体信号传导的功能基因组研究
  • 批准号:
    10389218
  • 财政年份:
    2021
  • 资助金额:
    $ 19.25万
  • 项目类别:
Visualizing the resolution of innate immune responses during influenza infection
可视化流感感染期间先天免疫反应的解决
  • 批准号:
    9899365
  • 财政年份:
    2020
  • 资助金额:
    $ 19.25万
  • 项目类别:
Identification of a Damaging Subset of Neutrophils that Arises in Septic Patients
脓毒症患者中出现的破坏性中性粒细胞亚群的鉴定
  • 批准号:
    10179456
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
  • 批准号:
    10646491
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
  • 批准号:
    9981638
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
Optical control of T cell metabolism
T细胞代谢的光学控制
  • 批准号:
    9910585
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
  • 批准号:
    9814149
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了